HOPE Therapeutics, and NRx Pharmaceuticals, Agreement $27 Million Funding
January 28, 2025
HOPE Therapeutics, a medical and technology driven company, and a wholly-owned subsidiary of NRx Pharmaceuticals, announced the signing and of a Stock Purchase Agreement (“SPA”)